IBDEI0QB ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,12047,1,4,0)
 ;;=4^G91.2
 ;;^UTILITY(U,$J,358.3,12047,2)
 ;;=^5004174^F02.81
 ;;^UTILITY(U,$J,358.3,12048,0)
 ;;=G91.2^^68^695^23
 ;;^UTILITY(U,$J,358.3,12048,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12048,1,3,0)
 ;;=3^NPH w/ Dementia w/o Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,12048,1,4,0)
 ;;=4^G91.2
 ;;^UTILITY(U,$J,358.3,12048,2)
 ;;=^5004174^F02.80
 ;;^UTILITY(U,$J,358.3,12049,0)
 ;;=G30.8^^68^695^5
 ;;^UTILITY(U,$J,358.3,12049,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12049,1,3,0)
 ;;=3^Alzheimer's Diseases NEC
 ;;^UTILITY(U,$J,358.3,12049,1,4,0)
 ;;=4^G30.8
 ;;^UTILITY(U,$J,358.3,12049,2)
 ;;=^5003807
 ;;^UTILITY(U,$J,358.3,12050,0)
 ;;=G31.09^^68^695^16
 ;;^UTILITY(U,$J,358.3,12050,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12050,1,3,0)
 ;;=3^Frontotemporal Dementia NEC
 ;;^UTILITY(U,$J,358.3,12050,1,4,0)
 ;;=4^G31.09
 ;;^UTILITY(U,$J,358.3,12050,2)
 ;;=^329916
 ;;^UTILITY(U,$J,358.3,12051,0)
 ;;=G20.^^68^695^24
 ;;^UTILITY(U,$J,358.3,12051,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12051,1,3,0)
 ;;=3^Parkinson's Disease w/ Dementia w/ Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,12051,1,4,0)
 ;;=4^G20.
 ;;^UTILITY(U,$J,358.3,12051,2)
 ;;=^5003770^F02.81
 ;;^UTILITY(U,$J,358.3,12052,0)
 ;;=G20.^^68^695^25
 ;;^UTILITY(U,$J,358.3,12052,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12052,1,3,0)
 ;;=3^Parkinson's Disease w/ Dementia w/o Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,12052,1,4,0)
 ;;=4^G20.
 ;;^UTILITY(U,$J,358.3,12052,2)
 ;;=^5003770^F02.80
 ;;^UTILITY(U,$J,358.3,12053,0)
 ;;=G31.01^^68^695^26
 ;;^UTILITY(U,$J,358.3,12053,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12053,1,3,0)
 ;;=3^Pick's Disease
 ;;^UTILITY(U,$J,358.3,12053,1,4,0)
 ;;=4^G31.01
 ;;^UTILITY(U,$J,358.3,12053,2)
 ;;=^329915
 ;;^UTILITY(U,$J,358.3,12054,0)
 ;;=G23.1^^68^695^28
 ;;^UTILITY(U,$J,358.3,12054,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12054,1,3,0)
 ;;=3^Progressive Supranuclear Ophthalmoplegia
 ;;^UTILITY(U,$J,358.3,12054,1,4,0)
 ;;=4^G23.1
 ;;^UTILITY(U,$J,358.3,12054,2)
 ;;=^5003780
 ;;^UTILITY(U,$J,358.3,12055,0)
 ;;=Z79.2^^68^696^1
 ;;^UTILITY(U,$J,358.3,12055,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12055,1,3,0)
 ;;=3^Antibiotics
 ;;^UTILITY(U,$J,358.3,12055,1,4,0)
 ;;=4^Z79.2
 ;;^UTILITY(U,$J,358.3,12055,2)
 ;;=^321546
 ;;^UTILITY(U,$J,358.3,12056,0)
 ;;=Z79.01^^68^696^2
 ;;^UTILITY(U,$J,358.3,12056,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12056,1,3,0)
 ;;=3^Anticoagulants
 ;;^UTILITY(U,$J,358.3,12056,1,4,0)
 ;;=4^Z79.01
 ;;^UTILITY(U,$J,358.3,12056,2)
 ;;=^5063330
 ;;^UTILITY(U,$J,358.3,12057,0)
 ;;=Z79.02^^68^696^3
 ;;^UTILITY(U,$J,358.3,12057,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12057,1,3,0)
 ;;=3^Antiplatelets/Antithrombotics
 ;;^UTILITY(U,$J,358.3,12057,1,4,0)
 ;;=4^Z79.02
 ;;^UTILITY(U,$J,358.3,12057,2)
 ;;=^5063331
 ;;^UTILITY(U,$J,358.3,12058,0)
 ;;=Z79.82^^68^696^4
 ;;^UTILITY(U,$J,358.3,12058,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12058,1,3,0)
 ;;=3^Aspirin
 ;;^UTILITY(U,$J,358.3,12058,1,4,0)
 ;;=4^Z79.82
 ;;^UTILITY(U,$J,358.3,12058,2)
 ;;=^5063340
 ;;^UTILITY(U,$J,358.3,12059,0)
 ;;=Z79.4^^68^696^5
 ;;^UTILITY(U,$J,358.3,12059,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12059,1,3,0)
 ;;=3^Insulin
 ;;^UTILITY(U,$J,358.3,12059,1,4,0)
 ;;=4^Z79.4
 ;;^UTILITY(U,$J,358.3,12059,2)
 ;;=^5063334
 ;;^UTILITY(U,$J,358.3,12060,0)
 ;;=Z79.1^^68^696^7
 ;;^UTILITY(U,$J,358.3,12060,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12060,1,3,0)
 ;;=3^NSAID
 ;;^UTILITY(U,$J,358.3,12060,1,4,0)
 ;;=4^Z79.1
 ;;^UTILITY(U,$J,358.3,12060,2)
 ;;=^5063332
